In vitro sensitivity of human metapneumovirus to type I interferons

Carolina Scagnolari1, Simona Trombetti, Carla Selvaggi

  • 1Department of Molecular Medicine, Laboratory of Virology, Sapienza University of Rome, Rome, Italy.

Viral Immunology
|April 1, 2011
PubMed

Insights

Human metapneumovirus (hMPV) shows partial resistance to type I interferons (IFN). This suggests a need for further research into how hMPV

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Human metapneumovirus (hMPV) is a significant respiratory pathogen.
  • Limited data exists on the interaction between hMPV and type I interferons (IFN).

Purpose of the Study:

  • To investigate the in vitro sensitivity of hMPV to type I interferons (IFN-β, IFN-α subtypes).
  • To compare the antiviral activity of IFNs against hMPV and a known IFN-sensitive virus.

Main Methods:

  • Utilized a human Hep-2 cell line for in vitro experiments.
  • Determined 50% inhibitory concentration (IC50) values for various type I IFN preparations against hMPV.
  • Compared IC50 values with those obtained for vesicular stomatitis virus (VSV).

Main Results:

  • hMPV exhibited significantly higher IC50 values compared to VSV, indicating partial resistance to type I IFNs.
  • Varied potency among IFN-α subtypes was observed, with subtypes 5, 6, 8, and 10 being most effective, and 2, 17, and 21 least effective.
  • Overall, hMPV demonstrated partial resistance to the antiviral effects of type I IFNs in Hep-2 cells.

Conclusions:

  • hMPV displays partial resistance to the antiviral activity of type I interferons in vitro.
  • Further investigation is needed to determine the clinical implications of hMPV's reduced IFN sensitivity.
  • Understanding this relationship may offer insights into hMPV pathogenesis and treatment strategies.